ADB launches US$9b Asia Pacific Vaccine Access Facility

BernamaPublished: Dec 11, 2020 12:55 PM

The Asian Development Bank (ADB) has launched a US$9 billion vaccine initiative, the Asia Pacific Vaccine Access Facility (APVAX), offering rapid and equitable support to its developing members to procure and deliver effective and safe Covid-19 vaccines.

President Masatsugu Asakawa said ADB’s developing members needed financing to procure vaccines as well as appropriate plans and knowledge to be able to safely, equitably and efficiently manage the vaccination process...

Sanofi and GSK delay Covid-19 vaccine, marking setback for global fight

AstraZeneca to test combining Covid-19 vaccine with Russian shot

US FDA advisers overwhelmingly endorse Pfizer Covid-19 vaccine

What the UK allergic reaction cases mean for Pfizer's Covid-19 vaccine

Universal access to affordable vaccine is crucial - foreign minister

Two report severe allergic reaction after getting Pfizer's Covid-19 vaccine

What happens after taking Pfizer's Covid-19 vaccine?

Testing times: More work needed on Astra/Oxford vaccine trials

British grandma is first in world to get Pfizer vaccine outside trials

Comments0

By posting a comment, you agree to our Commenting Terms and Conditions as stipulated in full here.

Do's and don'ts when posting comments in Malaysiakini

TERMS & CONDITIONS

Foul language, profanity, vulgarity, slanderous, personal attack, threatening, sexually-orientated comments or the use of any method of communication that may violate any law or create needless unpleasantness will not be tolerated. Antisocial behaviour such as "spamming" and "trolling" will be suspended. Violators run the risk of also being blocked permanently.

REPORT VIOLATORS

Please use the report feature that is available below each comment to flag offending comments for our moderators to take action. Do not take matters in your own hands to avoid unpleasant and unnecessary exchanges that may result in your own suspension or ban.

NOTICE

Our commenting system is still under development. We have taken note of feedback provided.

Subscriber-only space: